Ascendis Pharma (NASDAQ:ASND) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Ascendis Pharma (ASND) operate in?

Ascendis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Ascendis Pharma Stock (NASDAQ: ASND) stock price, news, charts, stock research, profile.

Open	$136.06
Close	$134.18
Volume / Avg.	147.81K / 374.34K
Day Range	133.02 - 136.78
52 Wk Range	85.29 - 161.00
Market Cap	$7.67B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	8.7%
Days to Cover	12.73

Recent News

FDA Pushes Review Date For Ascendis Pharma's Hormone Disorder Candidate By Three Months

Ascendis Pharma announces FDA's extension of the review date for TransCon PTH for adults with hypoparathyroidism to August 14, 2024. TransCon PTH aims to address low calcium levels due to hypoparathyroidism.

Vandana Singh

These Five Small-Cap Stocks Under The Radar Are Expected To Surge, Says Stock Researcher

Ethan Meyers, the research director at Westfield Capital Management, has a knack for identifying promising investments that have proven fruitful, especially for the Harbor Small Cap Growth Fund, where Westfield is a subadviser.

Bibhu Pattnaik

Ascendis Pharma's Growth Hormone Deficiency Candidate Outperforms in Phase 3 Trial

Ascendis Pharma A/S (NASDAQ: ASND) released topline results from Phase 3 foresiGHt trial to compare the efficacy and safety of TransCon hGH (lonapegsomatropin) with placebo and daily hGH (human growth hormone, somatropin) in adults with growth

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

Apr

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Ascendis Pharma A/S

Sector

Health Care

Industry

Biotechnology

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to a...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Ascendis Pharma (ASND) stock?

You can purchase shares of Ascendis Pharma (NASDAQ:ASND) through any online brokerage.

View our list of the best stock brokerages

Who are Ascendis Pharma (ASND) competitors?

Other companies in Ascendis Pharma’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).

What is the target price for Ascendis Pharma (ASND) stock?

There is no analysis for Ascendis Pharma.

What is the forecast for Ascendis Pharma (ASND) stock?

Ascendis Pharma has a consensus price target of $158.68.

Current stock price for Ascendis Pharma (ASND)?

The stock price for Ascendis Pharma (NASDAQ: ASND) is $134.18 last updated Today at July 3, 2024 at 1:00 PM EDT.

Does Ascendis Pharma (ASND) pay a dividend?

There are no upcoming dividends for Ascendis Pharma.

When is Ascendis Pharma (NASDAQ:ASND) reporting earnings?

Ascendis Pharma’s Q2 earnings are confirmed for Tuesday, September 3, 2024.

Is Ascendis Pharma (ASND) going to split?

There is no upcoming split for Ascendis Pharma.

What sector and industry does Ascendis Pharma (ASND) operate in?

Ascendis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Ascendis Pharma

Ascendis Pharma (ASND) Forecast